27th March 2018
- 0 comments
Renephra, a medical device company, today announced that it has raised £231,000 from Deepbridge Capital and the GM&C Life Sciences Fund, managed by Catapult Ventures.
Renephra, spun out of The University of Manchester and Manchester University NHS Foundation Trust by UMI3 Ltd, is developing an innovative medical device to treat patients with chronic oedema and fluid overload. Renephra's Transdermal Fluid Removal (TFR) technology enables the extraction of excess fluid through the skin using disposable microneedle patches and overcomes many of the issues with current treatments.
In order to read the full story we need you to be registered with us, please click the links below to login or register.